GSK Touts Alli As Tip Of OTC Strength, Reaffirms Consumer Commitment

By Malcolm Spicer / Email the Author / “The Tan Sheet” Jul. 30, 2007, Vol. 15, No. 031
Sales & Earnings / Word Count: 705 / Article # 05150310010

Executive Summary

Sales exceeding $150 million in two weeks on retail shelves for OTC weight-loss drug alli figure prominently in GlaxoSmithKline's commitment to its consumer health care products division, senior executives say

Purchase this Article

$50.00 Buy Now

For $50.00, purchase this 705-word article and receive immediate online access. 100% Satisfaction Guarantee.

View a complete sample article »

Already a Subscriber?

Log in for complete access.

Questions?

Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.

Log In

Email Address

Password

Remember Me

Forgot your password?

Don’t Have an Account?

If your employer has a site license, create your account to begin using it. Simply click ‘Create An Account’ button below to register now.

Otherwise, please explore our free content subscriptions.

Create an account

Enter the email address associated with your account and a temporary password will be sent to you.

Email Address

Need help? Contact us at (800) 332-2181, +1 (908) 547-2159, or custcare@elsevier.com

Email Article

* Required field

* To:

For multiple recipients, separate email addresses with a semi-colon.

* Your Name:

* Your Email:

Subject: GSK Touts Alli As Tip Of OTC Strength, Reaffirms Consumer Commitment

* Add a personalized message to your email:

Please Note: Only individuals with subscriptions to “The Tan Sheet” will be able to access the full article. All other readers will be directed to the abstract and may purchase the article.

or Cancel

GSK Touts Alli As Tip Of OTC Strength, Reaffirms Consumer Commitment

Executive Summary

Purchase this Article

Already a Subscriber?

Questions?

Related Articles: 8

Elsevier Business Intelligence Publications

Offers & Events

Topics Covered in this Article

Email Article